Sponsored Links
| TMX-67 (ULORIC(r)) Launches In Canada - Novel Drug For Chronic Management Of Hyperuricemia In Gout Patients |
 |
 |
 |
| Medical News - Gout | |||
|
Teijin Pharma Limited, the core company of the Teijin Group's medical and pharmaceutical business, announced today the launch of TMX-67 (febuxostat), a novel drug discovered by Teijin Pharma for the treatment of hyperuricemia in patients with gout, in Canada on Oct. 21, EST. Takeda Canada, Inc... Read more: Gout News From Medical News Today
|